• Something wrong with this record ?

Low-molecular weight chitosan enhances antibacterial effect of antibiotics and permeabilizes cytoplasmic membrane of Staphylococcus epidermidis biofilm cells

P. Kašparová, M. Zmuda, E. Vaňková, O. Maťátková, J. Masák

. 2021 ; 66 (6) : 983-996. [pub] 20210721

Language English Country United States

Document type Journal Article

Grant support
CZ.2.16/3.1.00/24503 Operational Programme Prague - Competitiveness
NPU I LO1601 National Programme of Sustainability I

This study evaluated the effect of low-molecular weight chitosan on Staphylococcus epidermidis, a common colonizer of joint implants and other prosthetic devices. We have also attempted to elucidate its mechanism of action. Chitosan was found to be effective against both the planktonic and biofilm cells (MIC80 35-40 mg/L; MBIC80 40-150 mg/L), in contrast to the antibiotics erythromycin and tetracycline with no antibiofilm activity (MBIC80 not found). In combination, chitosan had an additive effect with antibiotics on suspension growth of S. epidermidis (FICi 0.7-1.0), and the combinatory action caused a complete inhibition of biofilm metabolic activity in some cases. In addition, chitosan caused rapid cellular damage and enhanced antihaemolytic activity of tetracycline in combination towards S. epidermidis biofilm cells. Chitosan efficiently inhibited S. epidermidis growth acting via cell membrane damage, yet the extent of antimicrobial and antibiofilm activities was quite strain-specific. It was proved to be a very efficient antimicrobial agent worth further examination as a potent candidate in pharmaceutical research. Apart from antimicrobial activity, it also acted as antivirulence enhancing agent which is a very promising strategy for alternative infectious diseases treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21029460
003      
CZ-PrNML
005      
20230601084849.0
007      
ta
008      
211206s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-021-00898-6 $2 doi
035    __
$a (PubMed)34291404
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kašparová, Petra $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice 166 28, Prague, Czech Republic. kasparop@vscht.cz
245    10
$a Low-molecular weight chitosan enhances antibacterial effect of antibiotics and permeabilizes cytoplasmic membrane of Staphylococcus epidermidis biofilm cells / $c P. Kašparová, M. Zmuda, E. Vaňková, O. Maťátková, J. Masák
520    9_
$a This study evaluated the effect of low-molecular weight chitosan on Staphylococcus epidermidis, a common colonizer of joint implants and other prosthetic devices. We have also attempted to elucidate its mechanism of action. Chitosan was found to be effective against both the planktonic and biofilm cells (MIC80 35-40 mg/L; MBIC80 40-150 mg/L), in contrast to the antibiotics erythromycin and tetracycline with no antibiofilm activity (MBIC80 not found). In combination, chitosan had an additive effect with antibiotics on suspension growth of S. epidermidis (FICi 0.7-1.0), and the combinatory action caused a complete inhibition of biofilm metabolic activity in some cases. In addition, chitosan caused rapid cellular damage and enhanced antihaemolytic activity of tetracycline in combination towards S. epidermidis biofilm cells. Chitosan efficiently inhibited S. epidermidis growth acting via cell membrane damage, yet the extent of antimicrobial and antibiofilm activities was quite strain-specific. It was proved to be a very efficient antimicrobial agent worth further examination as a potent candidate in pharmaceutical research. Apart from antimicrobial activity, it also acted as antivirulence enhancing agent which is a very promising strategy for alternative infectious diseases treatment.
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    12
$a antiinfekční látky $7 D000890
650    _2
$a biofilmy $7 D018441
650    _2
$a buněčná membrána $7 D002462
650    12
$a chitosan $x farmakologie $7 D048271
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a molekulová hmotnost $7 D008970
650    _2
$a Staphylococcus epidermidis $7 D013212
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zmuda, Martin $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice 166 28, Prague, Czech Republic
700    1_
$a Vaňková, Eva $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice 166 28, Prague, Czech Republic
700    1_
$a Maťátková, Olga $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice 166 28, Prague, Czech Republic $7 jo2017970315
700    1_
$a Masák, Jan $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice 166 28, Prague, Czech Republic
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 66, č. 6 (2021), s. 983-996
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34291404 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211206 $b ABA008
991    __
$a 20230601084842 $b ABA008
999    __
$a ok $b bmc $g 1731460 $s 1150013
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 66 $c 6 $d 983-996 $e 20210721 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a CZ.2.16/3.1.00/24503 $p Operational Programme Prague - Competitiveness
GRA    __
$a NPU I LO1601 $p National Programme of Sustainability I
LZP    __
$a Pubmed-20211206

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...